tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Orchestra BioMed downgraded to Neutral from Buy at BTIG

BTIG downgraded Orchestra BioMed (OBIO) to Neutral from Buy without a price target The firm cites the company’s recent dilutive equity financing while maintaining its pace of spending for the downgrade. The funding reduces Orchestra’s future profitability while its key catalyst timelines have slipped over the past several quarters, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1